Pharmaceutical composition containing tedirosin
A technology of tediloxine and a composition, applied in the field of medicinal chemistry, can solve problems such as reduced therapeutic effect, and achieve the effects of long half-life, broad antibacterial spectrum and good therapeutic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1~4 and comparative example 1
[0016] Examples 1-4 are the preparation of Tedirosin composition injection, Table 1 shows the mass volume (W / V) percentage content of each component in Tedirosin composition injection in the present invention, The mixed solution was prepared according to the contents of each component in Table 1, filtered to volume with purified water, potted, and sterilized at 100° C. for 30 minutes to obtain the Tedirosin composition injection.
[0017] Comparative example 1 is the commodity Zuprevo of Intervet Company with Tedirosin as the main component, which contains 18% Tedirosin, 8.25% citric acid monohydrate is used to adjust the pH value, 40% propylene glycol, and the balance for water.
[0018] Table 1
[0019]
Tateroxin (%)
Citric acid to adjust the pH to
Example 1
1
10
/
5.5
Example 2
4
15
/
5.7
Example 3
10
20
/
5.6
Example 4
20
25
/
6...
Embodiment 5
[0050] This example is a study on Tediroxin Oral Liquid with a content of 10% (W / V).
[0051] One, the preparation of 10% Tideroxin Oral Liquid, the specific operation steps are:
[0052] (1) Add 60-70% water of the total volume of the prepared Tediroxin Oral Liquid into the preparation tank, stir, and adjust the pH value to 5.7-6.3 with 85% concentrated phosphoric acid.
[0053] (2) Add Tedirosin according to the amount.
[0054] (3) Use concentrated phosphoric acid with a concentration of 5%-100% to adjust the pH value to 5.5-6.0 to dissolve all the materials.
[0055] (4) Add 30% g of glycerin and stir to dissolve, warm to 50-60°C.
[0056] (5) Add water to 100ml, then filter through a 0.45 micron membrane filter to obtain the required Tediroxin oral liquid.
[0057] 2. Treatment test of oral liquid
[0058] 1. Select Dudu's long-term three-way hybrid commercial pigs, half male and half male, with an average body weight of 25.7-27.1kg, 80 in total; randomly divided into...
Embodiment 6
[0078] This example is a study on Tedirosin soluble powder with a weight percent content of 20%.
[0079] Preparation materials: tedirosin, tartaric acid, sodium tartrate, and sucrose as the carrier for the powder.
[0080] Preparation method: Take 200 g of taiderocin, 20 g of tartaric acid, 50 g of sodium tartrate, and 730 g of sucrose powder, mix them uniformly step by step, grind them, and pass through an 80-mesh sieve to obtain the soluble powder of the taideroxin composition.
[0081] Treatment effect: 90 sick pigs, the main clinical symptoms are cough, panting, dyspnea, identified as mycoplasma infection by PCR pathogen, were randomly divided into 3 groups according to body weight: the first group is the blank control group, no drug treatment The 2nd group treats with the Tedirosin soluble powder prepared by the present invention, and usage is 100g mixed with water 200L, drinking water, uses in succession 5 days, the 3rd group of drug control group is florfenicol soluble...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com